Nemaura Medical Inc. (NMRD)

NASDAQ: NMRD · IEX Real-Time Price · USD
2.73
-0.06 (-2.15%)
May 25, 2022 4:30 PM EDT - Market closed
Market Cap65.80M
Revenue (ttm)183,628
Net Income (ttm)-12.40M
Shares Out24.10M
EPS (ttm)-0.54
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume23,153
Open2.60
Previous Close2.79
Day's Range2.60 - 2.84
52-Week Range2.15 - 17.40
Beta0.12
AnalystsBuy
Price Target12.41 (+354.6%)
Earnings DateJul 5, 2022

About NMRD

Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company was founded in 2009 and is based in New York, New York.

IndustryHealth Care Equipment & Supplies
Founded2009
CEODewan Chowdhury
Employees25
Stock ExchangeNASDAQ
Ticker SymbolNMRD
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 9 analysts, the average rating for NMRD stock is "Buy." The 12-month stock price forecast is 12.41, which is an increase of 354.58% from the latest price.

Price Target
$12.41
(354.58% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Nemaura Medical Strengthens Balance Sheet with Further Non-Dilutive Funding

Loughborough, England, May 23, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on commercializing a daily disposable wearable glucose sensor and suppo...

3 days ago - GlobeNewsWire

MySugarWatch Continues Large-Scale Awareness Campaign Around Nemaura Medical's sugarBEAT Non-Invasive Continuous Gluc...

Loughborough, England, May 17, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on developing and commercializing wearable diagnostic devices and suppo...

1 week ago - GlobeNewsWire

Nemaura Medical to Present at the Planet MicroCap Showcase 2022

Loughborough, England, April 25, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing wearable diagnostic devices and sup...

1 month ago - GlobeNewsWire

Nemaura Medical to Present at the Maxim Group 2022 Virtual Growth Conference

Loughborough, England, March 24, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing wearable diagnostic devices and sup...

2 months ago - GlobeNewsWire

Nemaura Medical Wins Innovation Awards

Loughborough, England, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing wearabl...

2 months ago - GlobeNewsWire

Nemaura Medical Announces Fiscal Third Quarter 2022 Financial Results and Provides Business Update

Loughborough, England, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing wearabl...

3 months ago - GlobeNewsWire

Nemaura Medical Launches Metabolic Health Program for Employers and Insurers

Launch into commercial markets offers opportunit ies for faster and wider adoption of Mi b o k o program

4 months ago - GlobeNewsWire

Nemaura Medical to Present at the H.C. Wainwright Bioconnect 2022 Virtual Conference

Loughborough, England, Jan. 07, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic dev...

4 months ago - GlobeNewsWire

Nemaura Medical Completes Initial Shipment of CGM Devices to UK Licensee

Sales in UK expected to be followed by launches across major EU territories in 2022

5 months ago - GlobeNewsWire

Nemaura Medical Announces Fiscal Second Quarter 2022 Financial Results and Provides Business Update

Loughborough, England, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-inv...

6 months ago - GlobeNewsWire

Nemaura Medical to Present at the Diabetes Technology Society 2021 Conference on November 4, 2021

Loughborough, England, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic dev...

6 months ago - GlobeNewsWire

Nemaura Medical to Present at the LD Micro Main Event Conference

Loughborough, England, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic dev...

7 months ago - GlobeNewsWire

Nemaura Medical Launches Beta Version of Its Metabolic Health Program

MiBoKo , a noninvasive glucose sensor utilizing AI mobile application, addresses a substantia l multibillion-dollar market opportunity in healthcare

7 months ago - GlobeNewsWire

Nemaura Medical Announces Commercial Agreement with UK Licensee

Nemaura has previously placed order for 200,000 CGMs in anticipation of commercial ramp-up

7 months ago - GlobeNewsWire

Nemaura Medical Inc. (NASDAQ: NMRD) Diabetes, Obesity Solutions Differentiated in Form and Function

NEW YORK, Sept. 24, 2021 (GLOBE NEWSWIRE) -- NetworkNewsAudio -- Nemaura Medical Inc. (NASDAQ: NMRD)  announces the availability of a broadcast titled, “Healthcare Technologies Spearheading Modern Medic...

8 months ago - GlobeNewsWire

Nemaura Medical announce Professor Osama Hamdy Joins their Advisory Board

Loughborough, England, Sept. 17, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-inv...

8 months ago - GlobeNewsWire

Nemaura Medical Reports Financial Results and Provides Business Update for the First Fiscal Quarter Ended June 30, 2021

Loughborough, England, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-inv...

9 months ago - GlobeNewsWire

Nemaura Medical to Present at the Access to Giving Virtual Investor Conference on July 13, 2021

Loughborough, England, July 12, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic dev...

10 months ago - GlobeNewsWire

Nemaura Medical Announces Presentation on its Licensed Why WAIT Program During the American Diabetes Association 81st...

Loughborough, England, June 30, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-inv...

10 months ago - GlobeNewsWire

Nemaura Medical Reports Results and Provides Business Update for the Fiscal Year Ended March 31, 2021

Loughborough, England, June 30, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company commercializing sugarBEAT®, a non-invasive and flexible continuous ...

10 months ago - GlobeNewsWire

Nemaura Medical Makes Progress with Advanced Noninvasive Sensors for Diabetes Management and Metabolic Health

For millions of diabetic patients worldwide, the reality of constantly having needles pricked into the body for glucose monitoring can be a never-ending nightmare. With over 460 million people currently...

11 months ago - Benzinga

Nemaura Medical to Present at the LD Micro Virtual Invitational Conference on June 9, 2021

Loughborough, England, June 01, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic dev...

11 months ago - GlobeNewsWire

Neumaura Medical, Inc. to Present at the Summer Solstice - Best Ideas from the Buy Side Conference on June 2, 2021

Loughborough, England, May 26, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devi...

11 months ago - GlobeNewsWire

Former Penny Stocks To Watch Making Their Mark In 2021

These penny stocks hit it out of the park in 2021 & continue to climb in May. The post Former Penny Stocks To Watch Making Their Mark In 2021 appeared first on Penny Stocks to Buy, Picks, News and Infor...

Other symbols:GTBPOCGN
1 year ago - PennyStocks

Nemaura Medical Stages Epic Reversal

Shares of Nemaura Medical Inc. (NASDAQ:NMRD) may be about to drop even more than they have so far today. On Wednesday, the bulls were firmly in control.

1 year ago - Benzinga